Clinical Trial Update: Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of ispinesib in patients with advanced or metastatic non-small cell lung cancer has completed; results update is provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ispinesib (ispinesib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED